U.S. Health Secretary Unveils Plan to Accelerate Autism Diagnoses
Health Secretary launches an initiative to speed autism diagnoses, citing outdated processes and limited specialist availability.
Health
Read Full News
FDA clears first gene therapy for Sanfilippo A, opening new path for families
FDA approves Fayuvi for Sanfilippo A, the first dedicated treatment, raising questions on access, pricing and long-term monitoring.
Lawsuit Challenges NIH Practice of Screening Grant Applications for Banned Terms
Researchers sue NIH, alleging First Amendment violations after searches of grant applications for specific terms; case could reshape federal research funding reviews.
Fourth Measles-Related Death in Pennsylvania: 18-Year-Old Succumbs to Rare Neurological Complication
An 18-year-old in Mifflin County died of ADEM after measles, the state’s fourth measles-associated death; health authorities reiterate vaccination as prevention.
Court halts DHS four-year limit on visas for graduate students and postdocs
A federal judge has enjoined a DHS plan to cap visas for graduate students and postdocs at four years, pausing the rule while legal challenges continue.
Analysis Finds Pharma Side-Deals Could Erode Trump Plan’s Medicare Savings
Analysis suggests secret deals with drugmakers could slash projected Medicare savings from most-favored-nation pricing by up to 80%.
AstraZeneca’s Camizestrant Falls Short in Key First‑Line Breast Cancer Trial
AstraZeneca reports camizestrant did not beat standard therapy in SERENA-4 first-line trial, limiting its broader use beyond an existing U.S. approval.
Trump Pledges $500 Checks for Select ACA Enrollees Ahead of Midterms
Nearly 1 million ACA enrollees without federal subsidies will receive $500 checks from the Trump administration ahead of the midterms.
U.K. panel lays out 44 recommendations to regulate AI in healthcare
A U.K. commission issued 44 recommendations to govern adaptive medical AI, emphasizing staged approvals, performance monitoring and reporting.
Administration Confirms Four Permanent Leaders at the FDA
The administration has named four acting officials as permanent leaders at the FDA, overseeing drugs, biologics, tobacco and AI modernization.